IMR Press / FBL / Special Issues / 1326790897996038146
ADP-riboseNAD metabolism
Submission deadline: 31 December 2009
Special Issue Editor
Michael Hottiger
DVM, Ph.D., Institute of Veterinary Biochemistry and Molecular Biology, Winterthurerstrasse 190, 8057 Zurich, Switzerland
Interests: 64 publications, 19 grants, Editor of Frontiers in Bioscience
Keywords
Cell Biology
Molecular Biology
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (8 Papers)
Open Access Article
The molecular "Jekyll and Hyde" duality of PARP1 in cell death and cell survival
Paul O. Hassa
Front. Biosci. (Landmark Ed) 2009, 14(1), 72–111; https://doi.org/10.2741/3232
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
1
Download
44
Citations
9
Views
Open Access Article
The NMN/NaMN adenylyltransferase (NMNAT) protein family
Corinna Lau, Marc Niere, Mathias Ziegler
Front. Biosci. (Landmark Ed) 2009, 14(2), 410–431; https://doi.org/10.2741/3252
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
74
Download
85
Citations
70
Views
Open Access Article
Poly (ADP-ribose) glycohydrolase (PARG) and its therapeutic potential
Wookee Min, Zhao-Qi Wang
Front. Biosci. (Landmark Ed) 2009, 14(5), 1619–1626; https://doi.org/10.2741/3329
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
37
Download
63
Citations
55
Views
Open Access Article

Sensing NAD metabolites through macro domains

Susanne Till, Andreas G. Ladurner
Front. Biosci. (Landmark Ed) 2009, 14(9), 3246–3258; https://doi.org/10.2741/3448
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
11
Download
46
Citations
13
Views
Open Access Article
Enzymology of mammalian NAD metabolism in health and disease
Giulio Magni, Giuseppe Orsomando, Nadia Raffelli, Silverio Ruggieri
Front. Biosci. (Landmark Ed) 2008, 13(16), 6135–6154; https://doi.org/10.2741/3143
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
16
Download
71
Citations
9
Views
Open Access Article
Mammalian ADP-ribosyltransferases and ADP-ribosylhydrolases
Friedrich Koch-Nolte, Stefan Kernstock, Christoph Mueller-Dieckmann, Manfred S Weiss, Friedrich Haag
Front. Biosci. (Landmark Ed) 2008, 13(17), 6716–6729; https://doi.org/10.2741/3184
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
17
Download
80
Citations
18
Views
Open Access Article
DNA repair, insulin signaling and sirtuins: at the crossroads between cancer and aging
Raul Mostoslavsky
Front. Biosci. (Landmark Ed) 2008, 13(18), 6966–6990; https://doi.org/10.2741/3203
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
6
Download
8
Citations
7
Views
Open Access Article
The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases
Paul O. Hassa, Michael O. Hottiger
Front. Biosci. (Landmark Ed) 2008, 13(8), 3046–3082; https://doi.org/10.2741/2909
(This article belongs to the Special Issue ADP-riboseNAD metabolism)
101
Download
412
Citations
91
Views
Back to top